1. Home
  2. RGEN vs PSO Comparison

RGEN vs PSO Comparison

Compare RGEN & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.48

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Pearson Plc

PSO

Pearson Plc

HOLD

Current Price

$14.13

Market Cap

8.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
PSO
Founded
1981
1844
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Books
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
RGEN
PSO
Price
$166.48
$14.13
Analyst Decision
Buy
Analyst Count
10
0
Target Price
$174.90
N/A
AVG Volume (30 Days)
617.0K
694.3K
Earning Date
02-19-2026
03-03-2026
Dividend Yield
N/A
2.31%
EPS Growth
N/A
31.65
EPS
0.03
0.90
Revenue
$707,890,000.00
$4,822,578,436.00
Revenue This Year
$17.84
$2.36
Revenue Next Year
$12.44
$5.20
P/E Ratio
$6,513.01
$15.72
Revenue Growth
11.74
N/A
52 Week Low
$102.97
$12.85
52 Week High
$182.52
$17.90

Technical Indicators

Market Signals
Indicator
RGEN
PSO
Relative Strength Index (RSI) 58.72 63.44
Support Level $161.41 $14.05
Resistance Level $167.65 $14.23
Average True Range (ATR) 4.54 0.12
MACD 0.16 0.04
Stochastic Oscillator 89.26 84.85

Price Performance

Historical Comparison
RGEN
PSO

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About PSO Pearson Plc

UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.

Share on Social Networks: